RAJANGAM KANYA (Chief Medical & Devt. Officer) sold 14.6% of their position (1.48K shares) of SENTI BIOSCIENCES HOLDINGS, INC. on the open market
Open‑market sale worth $6.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/6/2025ACC: 0001854270-25-000002
Officer· Chief Medical & Devt. Officer
Since Jul 2022
-1.48K
Net shares
Net seller
$6.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.30K
Price / share
$4.07
Trade value
$5.28K
% of position
12.8%
2/4/2025
10.10K→8.80K
Common Stock
Direct
Shares
−182.00
Price / share
$4.37
Trade value
$795.34
% of position
2.1%
2/6/2025
8.80K→8.62K
Total
Net shares
−1.48K
Net value
-$6.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | S · Sale | −1.30K | $4.07 | $5.28K | 12.8% | 10.10K | 8.80K |
| Common Stock Direct | 2/6/2025 | S · Sale | −182.00 | $4.37 | $795.34 | 2.1% | 8.80K | 8.62K |
| Total | −1.48K | -$6.07K | ||||||
Derivative Transactions0
No derivative transactions reported